PerkinElmer, Inc. (PKI) - Financial and Strategic SWOT Analysis Review by GlobalData

VIEWS: 59 PAGES: 57

More Info
									        PerkinElmer, Inc. (PKI) - Financial and Strategic SWOT Analysis Review
        Reference Code: GDME1708FSA                                                                                           Publication Date: MAR 2012

          940 Winter Street                                  Phone              +1 781 6636900                  Revenue          1,921.3 (million USD)
          Waltham, MA                                        Fax                +1 781 4314255                  Net Profit       7.66 (million USD)
          02451                                              Website            www.perkinelmer.com             Employees        7,200
                                                                                PKI [New York Stock
          United States                                      Exchange                                           Industry         Medical Equipment
                                                                                Exchange]

       Company Overview
       PerkinElmer, Inc. (PerkinElmer) is a medical device company that engages in designing, manufacturing and marketing healthcare
       products and systems. The company operates through two business units, namely, Human Health and Environmental Health.
       The Human Health business develops research and diagnostic instrumentation technologies focuses on cellular research; clinical
       genetics and diagnostics; custom services; drug discovery; life science research; medical imaging technologies; and
       pharmaceutical development and manufacturing areas.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      PerkinElmer, Inc., SWOT Analysis
         Robert F. Friel                     Chairman                                 Strengths                              Weaknesses
         Nicholas A. Lopardo                 Director
                                                                                      Diversified Geographic                 Increasing Trade Receivables
         Alexis P. Michas                    Director                                 Presence
                                                                                                                             Increasing Operating Expenses
         James C. Mullen                     Director
                                                                                      Strong Research and
         Dr Vicki L. Sato                    Director                                 Development Capabilities
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData
                                                                                      Opportunities                          Threats
       Share Data
         PerkinElmer, Inc.                                                            Strategic Collaborations               Industry Consolidation
                                                                                                                             Challenges
        Share Price (USD) as on 23-Mar-                                27.33          Inorganic Growth Strategy
        2012                                                                                                                 Rapid Technological Change
        EPS (USD)                                                        0.01
        Market Cap (million USD)                                       3,082         Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
        Enterprise Value (million USD)                                 3,884
        Shares Outstanding (million)                                     113
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      Feb 16, 2012         PerkinElmer Announces Collaboration With
                                                                                                           Rutgers University Cell And DNA Repository
                                                                                                           To Improve Next Generation Sequencing
                                                                                                           Sample Access
                                                                                      Feb 06, 2012         PerkinElmer Expands Reagent Portfolio For
                                                                                                           Faster Identification Of Epigenetic Drug
                                                                                                           Candidates
                                                                                      Feb 02, 2012         PerkinElmer Reports Revenue Of $1.9 Billion
                                                                                                           In 2011
                                                                                      Feb 01, 2012         PerkinElmer Elects Peter Barrett To Board
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData                                                          Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData




PerkinElmer, Inc. (PKI) - Financial and Strategic SWOT Analysis                                                                 Reference Code: GDME1708FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       PerkinElmer, Inc. - Key Facts ............................................................................................................................................................. 5
       PerkinElmer, Inc. - Key Employees .................................................................................................................................................... 6
       PerkinElmer, Inc. - Key Employee Biographies .................................................................................................................................. 7
       PerkinElmer, Inc. - Major Products and Services ............................................................................................................................... 8
       PerkinElmer, Inc. - Medical Equipment Pipeline Products Data ....................................................................................................... 11
          PerkinElmer, Inc. Pipeline Products by Equipment Type .............................................................................................................. 11
          PerkinElmer, Inc. Pipeline Products by Development Stage......................................................................................................... 13
       PerkinElmer, Inc. - History ................................................................................................................................................................ 15
       PerkinElmer, Inc. - Company Statement .......................................................................................................................................... 20
       PerkinElmer, Inc. - Locations And Subsidiaries ................................................................................................................................ 21
          Head Office ................................................................................................................................................................................... 21
          Other Locations & Subsidiaries ..................................................................................................................................................... 21
       Section 2 – Company Analysis ......................................................................................................................................................... 27
       PerkinElmer, Inc. - Business Description.......................................................................................................................................... 27
       PerkinElmer, Inc. - Corporate Strategy ............................................................................................................................................. 28
       PerkinElmer, Inc. - SWOT Analysis .................................................................................................................................................. 29
          SWOT Analysis - Overview........................................................................................................................................................... 29
          PerkinElmer, Inc. - Strengths ........................................................................................................................................................ 29
             Strength - Diversified Geographic Presence ............................................................................................................................. 29
             Strength - Strong Research and Development Capabilities ...................................................................................................... 29
             Strength - Continuous Product Innovations ............................................................................................................................... 29
          PerkinElmer, Inc. - Weaknesses ................................................................................................................................................... 30
             Weakness - Increasing Trade Receivables ............................................................................................................................... 30
             Weakness - Increasing Operating Expenses ............................................................................................................................ 30
          PerkinElmer, Inc. - Opportunities .................................................................................................................................................. 30
             Opportunity - Strategic Collaborations....................................................................................................................................... 30
             Opportunity - Inorganic Growth Strategy ................................................................................................................................... 30
             Opportunity - Growth in Emerging Markets ............................................................................................................................... 31
          PerkinElmer, Inc. - Threats ........................................................................................................................................................... 31
             Threat - Industry Consolidation Challenges .............................................................................................................................. 31
             Threat - Rapid Technological Change ....................................................................................................................................... 31
             Threat - Uncertain R&D Outcomes ........................................................................................................................................... 31
       PerkinElmer, Inc. - Key Competitors ................................................................................................................................................ 32
       Section 3 – Company Financial Ratios ............................................................................................................................................. 33
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 33
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 33
       Performance Chart ........................................................................................................................................................................... 35
       Financial Performance...................................................................................................................................................................... 35
       Financial Ratios - Interim Ratios....................................................................................................................................................... 36
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 37
       Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances .................................................................................... 38


PerkinElmer, Inc. (PKI) - Financial and Strategic SWOT Analysis                                                                                                 Reference Code: GDME1708FSA
Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
          PerkinElmer, Inc., Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012 ................................................................. 38
          PerkinElmer, Inc., Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012 ................................................................ 39
       
								
To top